KMT2C-related NDD: genes and variants
Explore variant evidence for KMT2C-related NDD across 1 analyzed protein (KMT2C). Linked ClinVar records include 2 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 0 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-10-10. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to KMT2C-related NDD
KMT2C: Histone-lysine N-methyltransferase 2C
It helps establish enhancer-associated H3K4 methylation and thereby controls lineage-specific transcription together with other COMPASS-family proteins. Somatic loss-of-function alterations are frequent across cancers, while germline variants can cause neurodevelopmental phenotypes.
2 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in KMT2C have source records linked to KMT2C-related NDD. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to KMT2C-related NDD
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| KMT2C R4595C | 4595 | FYR N-terminal | Pathogenic / likely pathogenic (★) |
| KMT2C R4779G | 4779 | SET | Pathogenic / likely pathogenic (★) |
Diseases related to KMT2C-related NDD
- Urinary bladder cancer, also linked to KMT2C
- Multiple myeloma, also linked to KMT2C
- Medulloblastoma, also linked to KMT2C
- Kleefstra syndrome 2, also linked to KMT2C
Frequently asked questions
Which genes have records linked to KMT2C-related NDD?
This view contains 1 analyzed proteins: KMT2C. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 2 pathogenic or likely pathogenic variants, 1 variants of uncertain significance and 0 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 11 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center